ProQR Therapeutics PRQR
NASDAQ PRQR
$1.63 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

ProQR Therapeutics (PRQR) Gains from Investment Securities (2021 - 2023)

Updated

ProQR Therapeutics' Gains from Investment Securities came in at -$671,747 for the year ended Dec 31, 2023.

Analysis

ProQR Therapeutics (PRQR) Gains from Investment Securities (2021 - 2023) Analysis & Trends

  • Per Business Quant, earlier years put Gains from Investment Securities at -$608,266 in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 ProQR Therapeutics 171.74 Mn -291.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -676,014.69
Dec 31, 2021 -1.18 Mn
Mar 31, 2021 -749,072.62
API Access

ProQR Therapeutics Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=PRQR&period=max&api_key=YOUR_API_KEY